Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.
about
Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2Role of apolipoprotein E in neurodegenerative diseasesGenetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacksThe apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes)An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data.Gene-diet interactions and plasma lipoproteins: role of apolipoprotein E and habitual saturated fat intake.Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.Apolipoprotein E gene polymorphism and dyslipidaemia in adult Asian Indians: A population based study from Calcutta, IndiaLipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis.Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.Early identification of cardiovascular risk using genomics and proteomics.Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism.Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriersInfluence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.The expression of type III hyperlipoproteinemia: involvement of lipolysis genesContribution of regulatory and structural variations in APOE to predicting dyslipidemia.Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia)Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis.Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learnedMutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1Genetic association of apolipoprotein E polymorphisms with inflammatory bowel diseaseIntegrated role of two apoliprotein E polymorphisms on apolipoprotein B levels and coronary artery disease in a biethnic population.Zebrafish as a model for apolipoprotein biology: comprehensive expression analysis and a role for ApoA-IV in regulating food intake.Apolipoprotein E gene polymorphism and risk for coronary heart disease in the Chinese population: a meta-analysis of 61 studies including 6634 cases and 6393 controls.The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations.DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemiasRole of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.Human apolipoprotein E isoprotein subclasses are genetically determined.Genetics of the apolipoprotein E system in manIdentical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemiaSimultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome.Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemiaLong term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemiaDietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.Genetic alterations affecting cholesterol metabolism and human fertility
P2860
Q24310889-43D2A539-B447-4110-BEFF-16F6D4E27BAFQ26799413-C6F0B850-D87F-45B9-B6D7-F5222DBEFB68Q28241638-39745FE1-3BA5-48D0-A490-37463E185DE7Q28714850-1C38D991-E21A-4E14-BA64-E671A16B8000Q31160120-335B34A8-8762-4B1D-BA6D-0E0596F37EA8Q31709443-684236B5-38D6-4A41-BB75-677318CA02C4Q33403738-CDCB59B6-4010-43EE-843F-0875214FA0A7Q33735872-F73E92F4-9C66-4AD3-B2DF-1C5E24DF13EDQ33822165-C20B37E3-2788-4025-83EF-53268FB6A43DQ33867204-1C3C9D17-0FF1-4FAF-89B7-22A1882BDAE5Q33998681-93F28697-998B-48F4-AB44-26A34AB7C29EQ34129889-1184AE0D-DD7E-4AB5-8805-417C16EF5DBBQ34144158-C39779EC-183B-47CA-BD1D-164DD7BF07A9Q34185850-F58E1DE3-04C8-4456-9264-0CD54F7B5EDEQ34207532-5ACC9B4E-1820-4CDA-9280-B8C792924483Q34326186-247CA357-C531-43EF-9146-21AA1E919910Q34338601-576CF34B-D13A-4159-A541-1657B0387EF8Q34560246-F825E538-6F38-442D-B7C2-DAAFBC6B868EQ34563905-4ED6ACFC-0D20-460C-A47A-696C9CCC7026Q34606014-B19F3E83-000C-4EBC-AE44-41A9FC8FDB18Q34607518-0E35D07D-17B3-4068-B320-FE0980B05B8AQ34616680-8DB08DCF-F2FE-4EB1-AB45-3D57C01C6CC3Q34971549-E5545340-70B5-4CF3-AB81-F63D7DEBC44FQ34977880-3E634D87-99C9-4C33-AAAA-DFE7A148365BQ34986020-ACB6596D-D442-4F5F-9546-07B48720D2EDQ35075040-EBA9A12E-DB3B-41B8-8EAE-A79DE542420DQ35144039-1D9A2604-89D4-4CCF-8175-6B53CE470520Q35154972-A43EE2AF-55AE-4867-943E-DD41E80FB4ACQ35197088-9A2CB851-A73A-460C-B9E8-E42F83BE78DAQ35199071-7D687CE6-D352-4B4C-9283-4C467C9E4A03Q35200206-B6CD8BF7-02D3-4380-AF97-B4EC994D7327Q35201063-848B32AB-881F-436F-9334-9A29FC695A34Q35203817-878C5E18-4B41-4958-A500-960B6FA0DF06Q35205937-B44F299D-B8B4-4483-91F7-2A575A924575Q35246448-A84CF940-565F-4C5F-8E71-EE301B640E38Q35446554-64E0154C-39D5-402B-8DC9-7EDF6D8D794DQ35577335-117D30DB-991F-4D47-987D-061CA510DD35Q35580326-AF3EE789-3A5C-418C-BD21-EB405AEE0DCEQ35582832-E4FF14A3-C776-42CF-A699-50AEC830483EQ35617057-7D2B0E07-8040-4498-8B10-CCFAF98E1621
P2860
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.
@en
type
label
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.
@en
prefLabel
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.
@en
P2093
P2860
P356
P1433
P1476
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.
@en
P2093
P2860
P2888
P304
P356
10.1038/269604A0
P407
P577
1977-10-01T00:00:00Z
P6179
1022987026